Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAI in Metastatic Renal Carcinoma
NCT00006486Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2000
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carboxyamidotriazole in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Oct 2000; status: completed.
02
Drugs
carboxyamidotriazole
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00006486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006486.